All Type of News
Pharma industry focusing on products tailored for women
The pharmaceutical industry is focusing on attracting female consumers by specializing their products for women.
Pharmaceutical companies are currently developing whole new products just for the treatment of female-s...
Daewoong’s next management with Co-CEO Jae-Choon Yoon and Seung-Ho Jeon
The management of Daewoong Group announced to carry out the personnel reshuffle and focus on the global vision of 2020.
Daewoong Pharmaceutical(Jong-Wook Lee) held the 58th general meeting of stockholders and appoint...
About 20 pharmas including Hanmi Pharm compete in antithrombotic market
As ‘Brilinta Tab(generic name: ticagrelor),’a AstraZeneca’s antithrombotic, is expired in its PMS(Post-Marketing Surveillance), about 20 Korean pharmaceutical companies including Hanmi Pharm jumped into its market aft...
40th KMA President-Elect Dae-Jip Choi elected
No. 3 Candidate Dae-Jip Choi was selected as the 40th president of the Korean Medical Association(KMA).
According to the KMA’s electronic and mailing vote results on the 23rd, President-Elect Dae-Jip Choi was confirm...
1 of 3 listed pharmas making net profit/sales ratio even less than 1%
The polarization in profitability is reportedly getting serious as one of 3 listed pharmaceutical companies have a net profit ratio to sales less than 1%.
Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports tha...
Korea Exchange’s decision on Kyungnam Pharm to make subject to Substantive Examination for Listing Eligibility
The Exchange Korea reviewed possibilities to delist Kyungnam Pharm based on general qualifications in accordance with Article 38 of 2 Item of Number 2 of the KOSDAQ Rules, and officially announced that the company is ...
Daewoong Pharmaceutical signs co-promotion agreement of ‘Foxiga & Xigduo’ with AstraZeneca
Daewoong Pharmaceutical(CEO Jong-Wook Lee) signed a co-promotional partnership agreement of ‘Forxiga(dapagliflozin)’ and ‘Xigduo(dapagliflozin+metformin),’ SGLT-2 inhibitors for the treatment of type 2 diabetes with A...
MFDS approves 668 clinical trials with Hanmi Pharm acquired most 11 approvals
The Ministry of Food and Drug Safety(Minister Young-Jin Ryu, MFDS) analyzed approval of clinical trial plans in 2017, and the analysis result showed the number of approvals was 658 cases increased by 4.8% from the 201...
10 listed pharmas like Samsung Pharm don’t even have an ability to pay interests with operating profits they make
10 listed pharmaceutical companies, such as Samsung Pharm, Binex and Aprogen Pharmaceuticals(formerly known as Schnell Biopharmaceuticals), reportedly have no ability to pay interests for their debts with sales they m...
MOHW to strongly recommend pharmas to appeal in regards to innovative pharmaceutical company certificate revocation
In regards to the recently pre-announced administrative measure, the Ministry of Health and Welfare(MOHW) strongly recommended pharmaceutical companies to strongly appeal to standards of revoking the innovative pharma...
